XENE

Xenon Pharmaceuticals Inc

Exchange: NASDAQSector: HealthcareIndustry: Biotechnology

Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics. We are advancing an ion channel product portfolio to address areas of high unmet medical need, including epilepsy and depression. Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications.

Current Price

$54.12

-1.02%

Profile

Valuation (TTM)

Market Cap$4.50B

P/E-11.75

EV—

P/B7.74

Shares Out83.19M

P/Sales—

Revenue$0.00

EV/EBITDA—

Xenon Pharmaceuticals Inc (XENE) Company Profile

XENE Company Information

Xenon Pharmaceuticals is a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics.

We are advancing an ion channel product portfolio to address areas of high unmet medical need, including epilepsy and depression.

Azetukalner, a novel, highly potent, selective Kv7 potassium channel opener, represents the most advanced, clinically validated potassium channel modulator in late-stage clinical development for multiple indications.

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

British Columbia, Canada

XENE Key Officers

Key officers data coming soon

XENE Company Profile

Xenon Pharmaceuticals Inc (XENE) is a Healthcare company in the Biotechnology industry. It trades on NASDAQ. The company is based in British Columbia, Canada.

Market cap is $4.50B. There are 83.2M shares outstanding.

See the full Xenon Pharmaceuticals Inc profile on GoodMoat. It covers key officers, financial metrics, and sector details. You can also use GoodMoat's DCF calculator, fair value models, and quality score to help decide if XENE is a good investment.